Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia

Leukemia

Volumn 10, Issue 3, 1996, Pages 434-438

  Campos, L ^a,d   Sabido, O ^b   Sebban, C ^c   Charrin, C ^c   Bertheas, M F ^a   Fiere D ^c   Guyotat, D ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d HÔPITAL NORD   (France)

Author keywords

Acute lymphoblastic leukemia; Apoptosis; BCL 2 proto oncogene

Indexed keywords

ANTILEUKEMIC AGENT; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN BCL 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APOPTOSIS; ARTICLE; BLOOD CELL COUNT; CELL SURVIVAL; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0029929585     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hockenbery D, Nuñez G, Milliam C, Schreiber RD, Korsemeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
2. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JD, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993; 361: 365-369.
3. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-442.
4. Nunez C, Hockenbery D, McDonnell TJ, Sorensen CM, Korsemeyer SJ. Bcl-2 maintains B cell memory. Nature 1991; 353: 71-73.
5. Hockenberry DM, Zutter M, Hickey W, Nahm M, Korsemeyer SJ. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-6965.
6. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879-686.
7. Nuñez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsemeyer SJ. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990; 144: 3602-3610.
8. Tsujimoto Y. Stress-resistance conferred by high level of bcl-2 protein in human B lymphoblastoid cell. Oncogene 1989; 4: 1331-1335.
9. Nakayama K-i, Nakayama K, Negishi I, Kuida K, Shinkai Y, Louie MC, Fields, LE, Lucas PJ, Stewart V, Alt FW, Loh DY. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 1993; 261: 1584-1588.
10. Veis DJ, Sorensen CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis , polycystic kidneys, and hypopigmented hair. Cell 1993; 75: 229-240.
11. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 1993; 74: 609-619.
12. Boise LH, Gonzàlez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G, Thompson CB. Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74. 597-608.
13. Takavama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC. Cloning and functional analysis of BAG-1: a novel bcl-2 binding protein with anti-cell death activity. Cell 1995; 80: 279-284.
14. L and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285-291.
15. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995; 374: 733-736.
16. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995; 374: 736-739.
17. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986; 83: 5214-5218.
18. Reed JC, Tsujimoto Y, Alpers JA, Croce CM, Nowell PC. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 1987; 236: 1295-1297.
19. Pezzella F, Tse AG, Cordell JL, Pulford KA, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990; 137: 225-235.
20. Campana D, Coustan-Smith E, Manabe A, Buschle M, Raimondi SC, Behm FG, Ashmun R, Arico M, Biondi A, Pui CH. Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein. Blood 1993; 81: 1025-1031.
21. Pettersson M, Jernberg-Wiklund H, Larsson LG, Sundström C, Givol I, Tsujimoto Y, Nilsson K. Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood 1992; 79: 495-502.
22. Zutter M, Hockenbery D, Silverman GA, Korsemeyer SJ. Immunolocalization of the bcl-2 protein within hematopoietic neoplasms. Blood 1991; 78: 1062-1068.
23. Fière D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP, Varet B, Broustet B, Cahn JY, Rigal-Huguet F, Witz F, Michaux JL, Michallet M, Reiffers J. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as post-remission therapy. J Clin Oncol 1993; 11: 1990-2001.
24. Iffrah N, Harousseau JL, Jouet JP, Desablens B, Linassier C, Guyotat D, Witz F, Babin A, Brière J, Lamy T, Sadoun A, Pignon B, Flesch M, Caillot D, Abgrall JF, Casassus P, Berthaud P, Danel P, Boason M. Evaluation of an intensive and brief treatment including early ABMT and support by rGM-CSF in adult ALL: a GOELAMS study. 20th annual Meeting of the European Group for Bone Marrow Transplanation, Harrogate, UK, 1994 (Abstract 410).
25. Hoelzer D, Thiel H, Loffler H, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Müller U, Wendt F-C, Sodomann H, Rühl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken Ch, Hellriegel K-P, Spors S, Nowrousian RM, Fischer J, Fülle H, Mitrou PS, Pfreundschuh M, Görg Ch, Emmerich B, Queisser W, Meyer P, Labedzki L, Esseres U, Konig H, Mainzer K, Herrmann R, Messerer D, Zwingers T. Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia. Blood 1984; 64: 38-47.
26. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Archimbaud E, Vasselon C, Magaud JP, Guyotat D. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091-3096.
27. Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D. Bone marrow-derived stromal cells prevent apoptotic cells death in B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 2370-2377.
28. Sen S, D'Incalci M. Apoptosis: biochemical events and relevance to cancer chemotherapy. FEBS Lett 1992; 307: 122-127.
29. Alnemri ES, Fernandes TF, Halder S, Croce CM, Litwack G. Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B leukemias. Cancer Res 1992; 52: 491-495.
30. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993; 81: 151-157.
31. Kamesaki S, Kamesaki H, Jorgensen TJ, Tanizawa A, Pommier Y, Cossman J. Bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res 1993; 53: 4251-4256.
32. Tang C, Willingham MC, Reed JC, Miyashita T, Ray S, Ponnathpur V, Huang Y, Mahoney ME, Bullock G, Bhalla K. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. Leukemia 1994; 8: 1960-1969.
33. Campos L, Sabido O, Rouault JP, Guyotat D. Effects of BCL-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemia cells. Blood 1994; 84: 595-600.
34. Maung ZT, MacLean FR, Reid MM, Pearson ADJ, Proctor SJ, Hamilton PJ, Hall AG. The relationship between bcl-2 expression and response to chemotherapy in acute leukemia. Br J Haematol 1994; 88: 105-109.
35. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994; 83: 2038-2044.
36. Cuende E, Ales-Martinez JE, Ding L, Gonzalez-Garcia M, Martinez AC, Nun̄ez G. Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cells. EMBO J 1993; 12: 1555-1560.